BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16502798)

  • 1. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Pajonk FG
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 27387314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of acute and chronic psychoses in childhood and adolescence].
    Eggers Ch
    MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term treatment and rehabilitation of schizophrenic patients].
    Hofmann G; Schöny W
    Wien Klin Wochenschr Suppl; 1984; 154():4-8. PubMed ID: 6151756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptics--psychotherapy--psychiatric social work. In schizophrenia help is needed from many sides].
    Klingberg S; Längle G; Buchkremer G
    MMW Fortschr Med; 2003 Oct; 145(41):28-31. PubMed ID: 14655477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM
    Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early intervention in increased risk for schizophrenic illnesses. Multimodal psychotherapy--antipsychotic drugs only in treatment failure].
    Wieneke A; Bechdolf A; Schultze-Lutter F
    MMW Fortschr Med; 2000 Mar; 142(10):30-2. PubMed ID: 10748600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms].
    Müller-Spahn F; Modell S; Thomma M
    Nervenarzt; 1992 Jul; 63(7):383-400. PubMed ID: 1354331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current concepts of pharmacological treatment in schizophrenia].
    Jarema M
    Psychiatr Pol; 2002; 36(6):857-68. PubMed ID: 12725017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lifelong relapse prevention with antipsychotics in schizophrenia].
    Hasan A; Wobrock T
    Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rehabilitation in schizophrenia--guidelines for including psychosocial measures].
    Katschnig H
    Wien Med Wochenschr; 1998; 148(11-12):273-80. PubMed ID: 9746970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Longterm therapy of schizophrenia].
    Pajonk FG; Wobrock T; Falkai P
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract]   [Full Text] [Related]  

  • 19. The staging model in schizophrenia, and its clinical implications.
    Agius M; Goh C; Ulhaq S; McGorry P
    Psychiatr Danub; 2010 Jun; 22(2):211-20. PubMed ID: 20562749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia treatment guidelines in the United States.
    Moore TA
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):40-9. PubMed ID: 21459738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.